Morbidity and Treatment Regret in Men with Advanced Prostate Cancer

The question of today’s post is do men with advanced prostate cancer develop treatment regrets concurrent to their development of morbidity issues ( i.e.- myocardial infarction, congestive heart failure, angina, diabetes, stroke, circulation problems, inflammatory bowel disease, or amputation)? To answer this question researchers evaluated 795 men from the Comprehensive, Observational, Multicenter, Prostate Adenocarcinoma Registry [...]

Hey, Where Did the Summer Go?

I'm not the biggest fan of the summer. I don't like being covered in sweat when I get to work. I don't like being devoured by evil hungry mosquitoes. And I despise flying beetles sneaking into my home getting caught in my ceiling fan's down draft and landing in my sleeping face. I also don't [...]

By |2022-08-25T16:54:29-04:00September 4th, 2011|LIFE, SCHOOL DAZE, THE HOLIDAYS|1 Comment

New Data on Long-Term Use of Firmagon® (degarelix) For Men with Advanced Hormone Dependant Prostate Cancer

New data, published September 1 in the Journal of Urology, shows that Firmagon® (degarelix) which is a gonadotropin-releasing hormone therapy (GnRH) given to men with advanced prostate cancer may be superior to leuprolide when used over three years. This new study (CS21A) was an open-label extension of the Phase III study (CS21) in which Firmagon® [...]

Go to Top